These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33539963)

  • 1. Long noncoding RNAs-a new dimension in the molecular architecture of the bile acid/FXR pathway.
    Ma Y; Harris J; Li P; Cao H
    Mol Cell Endocrinol; 2021 Apr; 525():111191. PubMed ID: 33539963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FXR signaling in the enterohepatic system.
    Matsubara T; Li F; Gonzalez FJ
    Mol Cell Endocrinol; 2013 Apr; 368(1-2):17-29. PubMed ID: 22609541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy.
    Chiang JYL; Ferrell JM
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G554-G573. PubMed ID: 31984784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acids as metabolic regulators.
    Li T; Chiang JY
    Curr Opin Gastroenterol; 2015 Mar; 31(2):159-65. PubMed ID: 25584736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role of the bile salt receptor FXR in atherosclerosis.
    Hageman J; Herrema H; Groen AK; Kuipers F
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1519-28. PubMed ID: 20631352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear bile acid receptor FXR in the hepatic regeneration.
    Chen WD; Wang YD; Meng Z; Zhang L; Huang W
    Biochim Biophys Acta; 2011 Aug; 1812(8):888-92. PubMed ID: 21167938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile salts in control of lipid metabolism.
    Schonewille M; de Boer JF; Groen AK
    Curr Opin Lipidol; 2016 Jun; 27(3):295-301. PubMed ID: 27031274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile Acids as Hormones: The FXR-FGF15/19 Pathway.
    Kliewer SA; Mangelsdorf DJ
    Dig Dis; 2015; 33(3):327-31. PubMed ID: 26045265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
    Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
    Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice.
    Li P; Ruan X; Yang L; Kiesewetter K; Zhao Y; Luo H; Chen Y; Gucek M; Zhu J; Cao H
    Cell Metab; 2015 Mar; 21(3):455-67. PubMed ID: 25738460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress and challenges of selective Farnesoid X Receptor modulation.
    Massafra V; Pellicciari R; Gioiello A; van Mil SWC
    Pharmacol Ther; 2018 Nov; 191():162-177. PubMed ID: 29933033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FXR an emerging therapeutic target for the treatment of atherosclerosis.
    Mencarelli A; Fiorucci S
    J Cell Mol Med; 2010 Jan; 14(1-2):79-92. PubMed ID: 20041971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the Evolution of Bile Salts and the Farnesoid X Receptor in Vertebrates.
    Frisch K; Alstrup AKO
    Physiol Biochem Zool; 2018; 91(2):797-813. PubMed ID: 29315013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear bile acid receptor FXR as pharmacological target: are we there yet?
    Modica S; Moschetta A
    FEBS Lett; 2006 Oct; 580(23):5492-9. PubMed ID: 16904670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acid receptors in non-alcoholic fatty liver disease.
    Li Y; Jadhav K; Zhang Y
    Biochem Pharmacol; 2013 Dec; 86(11):1517-24. PubMed ID: 23988487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR.
    Wang H; Chen J; Hollister K; Sowers LC; Forman BM
    Mol Cell; 1999 May; 3(5):543-53. PubMed ID: 10360171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid promotes liver regeneration via farnesoid X receptor signaling pathways in rats.
    Ding L; Yang Y; Qu Y; Yang T; Wang K; Liu W; Xia W
    Mol Med Rep; 2015 Jun; 11(6):4431-7. PubMed ID: 25634785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acids: regulation of synthesis.
    Chiang JY
    J Lipid Res; 2009 Oct; 50(10):1955-66. PubMed ID: 19346330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.